NO20080103L - Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disse - Google Patents
Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disseInfo
- Publication number
- NO20080103L NO20080103L NO20080103A NO20080103A NO20080103L NO 20080103 L NO20080103 L NO 20080103L NO 20080103 A NO20080103 A NO 20080103A NO 20080103 A NO20080103 A NO 20080103A NO 20080103 L NO20080103 L NO 20080103L
- Authority
- NO
- Norway
- Prior art keywords
- milk
- caseins
- bioactive
- obtaining
- methods
- Prior art date
Links
- 230000000975 bioactive effect Effects 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102000011632 Caseins Human genes 0.000 title abstract 2
- 108010076119 Caseins Proteins 0.000 title abstract 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 title abstract 2
- 235000021240 caseins Nutrition 0.000 title abstract 2
- 229940021722 caseins Drugs 0.000 title abstract 2
- 230000002255 enzymatic effect Effects 0.000 title abstract 2
- 235000013336 milk Nutrition 0.000 title abstract 2
- 239000008267 milk Substances 0.000 title abstract 2
- 210000004080 milk Anatomy 0.000 title abstract 2
- 102000014171 Milk Proteins Human genes 0.000 abstract 2
- 108010011756 Milk Proteins Proteins 0.000 abstract 2
- 235000013305 food Nutrition 0.000 abstract 2
- 235000021239 milk protein Nutrition 0.000 abstract 2
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 abstract 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 abstract 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 abstract 1
- 230000003276 anti-hypertensive effect Effects 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
- A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
- A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Sammendrag Oppfinnelsen vedrører fremstillingen av bioaktive produkter som er avledet fra melkeproteiner i fremstillingen av bioaktive melkeprodukter som er avledet fra melkeproteiner, spesielt kaseiner. De 16 oppfinneriske peptidene kan bli fremskaffet kjemisk, bioteknologisk eller ved hjelp av enzymatisk behandling fra proteiner inneholdende de samme og gi opphav til peptider med antimikrobiell aktivitet, en in vitro angiotensinkonverterende enzyminhibitorisk aktivitet og/eller antihypertensiv aktivitet og/eller antioksidantaktivitet. Nevnte næringsmiddelprodukter er egnet for anvendelse i matvareindustrien og den fannasøytiske industrien, både i form av et hydrolysat eller bioaktive peptider.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200501373A ES2319475B1 (es) | 2005-06-08 | 2005-06-08 | Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion. |
PCT/ES2006/070079 WO2006131586A1 (es) | 2005-06-08 | 2006-06-08 | Péptidos bioactivos identificados en hidrolizados enzimáticos de caseínas lácteas y procedimiento de obtención |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20080103L true NO20080103L (no) | 2008-03-04 |
Family
ID=37498152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20080103A NO20080103L (no) | 2005-06-08 | 2008-01-07 | Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disse |
Country Status (12)
Country | Link |
---|---|
US (1) | US8354502B2 (no) |
EP (2) | EP2495250A3 (no) |
JP (1) | JP2008545774A (no) |
KR (1) | KR101343904B1 (no) |
CN (2) | CN103254278B (no) |
AU (1) | AU2006256720A1 (no) |
BR (1) | BRPI0611729A2 (no) |
CA (1) | CA2611416C (no) |
ES (1) | ES2319475B1 (no) |
MX (1) | MX2007015528A (no) |
NO (1) | NO20080103L (no) |
WO (1) | WO2006131586A1 (no) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10331202A1 (de) | 2003-07-10 | 2005-03-31 | S.K. Enterprise Gmbh | Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms |
WO2007110296A1 (en) * | 2006-03-24 | 2007-10-04 | Unilever N.V. | Healthy food product |
DE102006036285A1 (de) * | 2006-08-03 | 2008-02-07 | "S.U.K." Beteiligungs Gmbh | Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms |
EP2253324A1 (en) * | 2009-04-30 | 2010-11-24 | Consejo Superior De Investigaciones Cientificas | Use of a casein-derived peptide and compositions thereof as antihypertensive |
US20120322726A1 (en) * | 2010-02-24 | 2012-12-20 | Morinaga Milk Industry Co., Ltd. | Therapeutic agent for eating disorders |
CN103232526B (zh) * | 2012-12-12 | 2015-06-24 | 上海交通大学 | 一种生物活性多肽lplp及其制备和应用 |
US9138455B2 (en) | 2013-03-15 | 2015-09-22 | Mead Johnson Nutrition Company | Activating adiponectin by casein hydrolysate |
US9345741B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof |
US8889633B2 (en) | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
US9352020B2 (en) | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
US9289461B2 (en) | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
US9345727B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component and uses thereof |
CN103616454B (zh) * | 2013-12-06 | 2015-06-03 | 贝因美婴童食品股份有限公司 | 一种定量检测人β-酪蛋白含量的方法以及试剂盒 |
CN104073539B (zh) * | 2014-06-17 | 2017-03-29 | 黑龙江省乳品工业技术开发中心 | 一种牛乳β‑酪蛋白多元活性肽的制备方法及其应用 |
JP2017048124A (ja) * | 2015-08-31 | 2017-03-09 | 森永乳業株式会社 | アミノペプチダーゼa阻害剤 |
EP3170507B1 (en) | 2015-11-20 | 2022-12-21 | Consejo Superior de Investigaciones Científicas (CSIC) | Antihypertensive peptides from olive oil |
CN107337710A (zh) * | 2017-07-26 | 2017-11-10 | 盐城卫生职业技术学院 | 一种抗高血压活性肽The‑The‑Pro及应用和药物组合物 |
CN107814838A (zh) * | 2017-12-07 | 2018-03-20 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽ypqrdmpiqaf及其制备方法和应用 |
CN107880106B (zh) * | 2017-12-11 | 2020-06-16 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽vpitptlnre及其制备方法和应用 |
KR102073824B1 (ko) * | 2018-04-11 | 2020-02-05 | 강원대학교산학협력단 | 간 보호용 건강기능식품 및 이의 제조 방법 |
CN111606972B (zh) * | 2019-01-30 | 2022-04-05 | 浙江省医学科学院 | 一种鳕鱼皮寡肽及其分离纯化和在制备ɑ-葡萄糖苷酶抑制剂及抗Ⅱ型糖尿病药物中的应用 |
CN110498833B (zh) * | 2019-08-30 | 2021-01-15 | 华南理工大学 | 一种具有ace抑制作用的三肽及其应用 |
US11326176B2 (en) * | 2019-11-22 | 2022-05-10 | Mozza Foods, Inc. | Recombinant micelle and method of in vivo assembly |
CN111777665B (zh) * | 2020-07-24 | 2022-07-05 | 北京林业大学 | 一种核桃粕抗氧化肽faw及其制备方法与应用 |
CN115505025A (zh) * | 2022-11-10 | 2022-12-23 | 东北农业大学 | 一种基于老年人静态消化模型的乳清蛋白源抗氧化肽的筛选 |
CN116444608B (zh) * | 2022-11-30 | 2024-06-25 | 内蒙古伊利实业集团股份有限公司 | 乳源活性肽dpsffake及其制备方法与应用 |
CN116444609B (zh) * | 2022-11-30 | 2024-06-04 | 内蒙古伊利实业集团股份有限公司 | 乳源活性肽lppplpsrwpl及其制备方法与应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4444753C2 (de) * | 1994-12-15 | 1998-08-06 | Forssmann Wolf Georg | Antibiotisch wirksame Peptide aus der bovinen Milch, deren Gewinnung und Verwendung |
US6060448A (en) * | 1995-10-31 | 2000-05-09 | Pepsyn Limited | Casein fragments having growth promoting activity |
AUPP051497A0 (en) | 1997-11-24 | 1997-12-18 | University Of Melbourne, The | Antimicrobial peptides |
AU768673B2 (en) | 1998-09-15 | 2003-12-18 | Nizo Food Research | Process for producing peptides from biological fluids and peptides obtainable by said process |
US6514941B1 (en) | 1999-12-10 | 2003-02-04 | Campina Melkunie B.V. | Method of preparing a casein hydrolysate enriched in anti-hypertensive peptides |
IL134830A0 (en) * | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
NZ523036A (en) | 2000-05-08 | 2004-04-30 | Davisco Foods Internat Inc | Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals |
GB0016189D0 (en) * | 2000-06-30 | 2000-08-23 | Pepsyn Ltd | Cosmetic composition |
US6465432B1 (en) | 2000-08-28 | 2002-10-15 | Kraft Food Holdings, Inc. | Isolated antioxidant peptides form casein and methods for preparing, isolating, and identifying antioxidant peptides |
CA2458924A1 (en) * | 2001-08-30 | 2003-03-06 | Chay 13 Medical Research Group N.V. | Casein derived peptides and uses thereof in therapy |
US7309491B2 (en) * | 2003-04-11 | 2007-12-18 | Antigenics Inc. | Heat shock protein-based vaccines and immunotherapies |
WO2004089986A1 (en) | 2003-04-14 | 2004-10-21 | Stichting Voor De Technische Wetenschappen | Antimicrobial peptide from transferrin family |
-
2005
- 2005-06-08 ES ES200501373A patent/ES2319475B1/es active Active
-
2006
- 2006-06-08 AU AU2006256720A patent/AU2006256720A1/en not_active Abandoned
- 2006-06-08 CA CA2611416A patent/CA2611416C/en not_active Expired - Fee Related
- 2006-06-08 JP JP2008515233A patent/JP2008545774A/ja not_active Abandoned
- 2006-06-08 EP EP12158198.7A patent/EP2495250A3/en not_active Withdrawn
- 2006-06-08 US US11/921,797 patent/US8354502B2/en not_active Expired - Fee Related
- 2006-06-08 CN CN201310023562.3A patent/CN103254278B/zh not_active Expired - Fee Related
- 2006-06-08 MX MX2007015528A patent/MX2007015528A/es not_active Application Discontinuation
- 2006-06-08 BR BRPI0611729-5A patent/BRPI0611729A2/pt not_active IP Right Cessation
- 2006-06-08 EP EP06764378A patent/EP1905779A4/en not_active Withdrawn
- 2006-06-08 CN CN200680029333.0A patent/CN101305017B/zh not_active Expired - Fee Related
- 2006-06-08 WO PCT/ES2006/070079 patent/WO2006131586A1/es active Application Filing
-
2008
- 2008-01-07 NO NO20080103A patent/NO20080103L/no not_active Application Discontinuation
- 2008-01-08 KR KR1020087000546A patent/KR101343904B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2611416A1 (en) | 2006-12-14 |
WO2006131586A1 (es) | 2006-12-14 |
US20100048464A1 (en) | 2010-02-25 |
ES2319475B1 (es) | 2010-02-16 |
EP1905779A1 (en) | 2008-04-02 |
CN101305017B (zh) | 2014-08-06 |
KR101343904B1 (ko) | 2013-12-23 |
AU2006256720A1 (en) | 2006-12-14 |
EP1905779A4 (en) | 2010-09-01 |
CN103254278B (zh) | 2015-07-22 |
US8354502B2 (en) | 2013-01-15 |
CN103254278A (zh) | 2013-08-21 |
EP2495250A2 (en) | 2012-09-05 |
WO2006131586B1 (es) | 2007-02-01 |
EP2495250A3 (en) | 2013-07-10 |
JP2008545774A (ja) | 2008-12-18 |
CA2611416C (en) | 2015-10-06 |
MX2007015528A (es) | 2008-02-25 |
ES2319475A1 (es) | 2009-05-07 |
KR20080045108A (ko) | 2008-05-22 |
CN101305017A (zh) | 2008-11-12 |
BRPI0611729A2 (pt) | 2010-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20080103L (no) | Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disse | |
WO2007019176A3 (en) | Corn protein concentrates | |
WO2008131008A3 (en) | Protein hydrolysate compositions having improved sensory characteristics and physical properties | |
DK1765094T3 (da) | Produkt af hydrolyseret havprotein, fremgangsmåde til dens fremstilling og anvendelse | |
NO20083940L (no) | Fremgangsmater for redusering av proteinaggregering | |
MX2022008144A (es) | Composiciones alimenticias con alto contenido de proteinas. | |
WO2011156380A3 (en) | Protein-containing adhesives, and manufacture and use thereof | |
BR112012026906A2 (pt) | método para obtenção de produtos nutritivos à base de leguminosas | |
DK1996028T3 (da) | Faste enzymformuleringer og fremgangsmåde til deres fremstilling | |
MX2012001923A (es) | Composicion con alto contenido proteico para la industria alimenticia. | |
WO2007046891A3 (en) | Systems and methods for separating proteins from connective tissue | |
EA200800289A1 (ru) | Новые ферменты для ферментативного отбеливания пищевых продуктов | |
MX2022010931A (es) | Composiciones estructuradas analogas a la carne con alto contenido de proteinas. | |
Welsh et al. | Comparison of bioactive peptides prepared from sheep cheese whey using a food‐grade bacterial and a fungal protease preparation | |
WO2005071067A3 (en) | Non-animal origin stabilizers and processes for producing the same | |
WO2010002160A3 (ko) | 돼지의 알파에스 1 카제인 유전자, 그 프로모터 및 그의 용도 | |
WO2023012109A3 (en) | Microbiota engineering | |
ATE493999T1 (de) | Nahrungsmittel enthaltend dipeptide mit blutdrucksenkenden eigenschaften. | |
WO2018132821A3 (en) | Elastomeric proteins | |
ATE472316T1 (de) | Haarbehandlungszusammensetzungen | |
WO2006029538A8 (en) | Sialyltransferases comprising conserved sequence motifs | |
PH12019502185A1 (en) | Hydrolysed vegetable proteins suitable for use in baby food | |
WO2015009829A3 (en) | Enhancement of osteogenic potential of bone grafts | |
ATE494794T1 (de) | Ovo-lacto-vegetarisches nahrungsmittel oder nahrungsmittelzwischenprodukt | |
이지수 et al. | Antioxidant and ACE inhibitory activities of soybean hydrolysates: Effect of enzyme and degree of hydrolysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |